193
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

The Ethanolic Extract of Bark from Salix Aegyptiaca L. Inhibits the Metastatic Potential and Epithelial to Mesenchymal Transition of Colon Cancer Cell Lines

&
Pages 999-1008 | Received 17 Sep 2013, Accepted 30 Apr 2014, Published online: 31 Aug 2014

REFERENCES

  • Lee YC, Lin HH, Hsu CH, Wang CJ, Chiang TA, et al.: Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. Eur J Pharmacol 632, 23–32, 2010.
  • Wu Y and Zhou BP: New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin 40, 643–650, 2008.
  • Uttamsingh S, Bao X, Nguyen KT, Bhanot M, Gong J, et al.: Synergistic effect between EGF and TGF-beta 1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 27, 2626–2634, 2008.
  • Grande M, Franzen A, Karlsson JO, Ericson LE, Heldin NE, et al.: Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 115, 4227–4236, 2002.
  • Qin Q, Xu Y, He T, Qin C, and Xu J: Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res 22, 90–106, 2012.
  • Xu J, Lamouille S, and Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19, 156–172, 2009.
  • Jang TJ, Jeon KH, and Jung KH: Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers. Yonsei Med J 50, 818–824, 2009.
  • Schmalhofer O, Brabletz S, and Brabletz T: E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metast Rev 28, 151–166, 2009.
  • Peinado HC, Portillo F, and Cano A: Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48, 365–375, 2004.
  • Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, et al.: The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2, 84–89, 2000.
  • Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al.: The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2, 76–83, 2000.
  • Androutsopoulos V, Arroo RRJ, Hall JF, Surichan S, and Potter GA: Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism. Breast Cancer Res 10, R39, 2008.
  • Liu RH: Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 78, 517S–520S, 2003.
  • Chrubasik S, Kunzel O, Model A, Conradt C, and Black A: Treatment of low back pain with a herbal or synthetic anti-rheumatic: a randomized controlled study. Willow bark extract for low back pain. Rheumatology 40, 1388–1393, 2001.
  • Fiebich BL and Chrubasik S: Effects of an ethanolic Salix extract on the release of selected inflammatory mediators in vitro. Phytomedicine 11, 135–138, 2004.
  • Hostanska K, Jurgenliemk G, Abel G, Nahrstedt A, and Saller R: Willow bark extract (BNO1455) and its fractions suppress growth and induce apoptosis in human colon and lung cancer cells. Cancer Detect Prev 31, 129–139, 2007.
  • Barrett B, Kiefer D, and Rabago D: Assessing the risks and benefits of herbal medicine: An overview of scientific evidence. Altern Ther Health Med 5, 40–49, 1999.
  • Cragg GM and Newman DJ: Natural product drug discovery in the next millennium. Pharm Biol 39, 8–17, 2001.
  • Levesque H and Lafont O: Aspirin throughout the ages: an historical review. Rev Med Interne 21, 8S–17S, 2000.
  • Enayat S and Banerjee S: Comparative antioxidant activity of extracts from leaves, bark and catkins of Salix aegyptiaca sp. Food Chem 116, 23–28, 2009.
  • Enayat S, Ceyhan M, Basaran A, Gursel M, and Banerjee S: Anticarcinogenic effects of the ethanolic extract of Salix aegyptiaca in colon cancer cells: involvement of Akt/PKB and MAPK pathways. Nutr Cancer 65, 1048–1058, 2013.
  • N’Guessan JD, Bidie AP, Lenta BN, Weniger B, Andre P, et al.: In vitro assays for bioactivity-guided isolation of antisalmonella and antioxidant compounds in Thonningia sanguinea flowers. AJB 6, 1685–1689, 2007.
  • Gezer K, Duru ME, Kivrak I, Turkoglu A, Mercan N, et al.: Free-radical scavenging capacity and antimicrobial activity of wild edible mushroom from Turkey. AJB 5, 1924–1928, 2006.
  • Kim DO, Jeong SW, and Lee CY: Antioxidant capacity of phenolic phytochemicals from various cultivars of plums. Food Chem 81, 321–326, 2003.
  • Adya R, Tan BK, Punn A, Chen J, and Randeva HS: Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc Res 78, 356–365, 2008.
  • Zuo JH, Zhu W, Li MY, Li XH, Yi H, et al.: Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-Like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 112, 2508–2517, 2011.
  • Gialeli C, Theocharis AD, Kletsas D, Tzanakakis GN, and Karamanos NK: Expression of matrix macromolecules and functional properties of EGF-responsive colon cancer cells are inhibited by panitumumab. Invest New Drug 31, 516–524, 2013.
  • Wu SJ, Gan Y, Wang XH, Liu J, Li MJ, et al.: PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis. J Cancer Res Clin 139, 891–900, 2013.
  • Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S, et al.: Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol 73, 1024–1032, 2007.
  • Bravo L: Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56, 317–333, 1998.
  • Hollman PCH, Devries JHM, Vanleeuwen SD, Mengelers MJB, and Katan MB: Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 62, 1276–1282, 1995.
  • Lee MJ, Wang ZY, Li H, Chen L, Sun Y, et al.: Analysis of plasma and urinary tea polyphenols in human-subjects. Cancer Epidem Biomar 4, 393–399, 1995.
  • Taddei ML, Giannoni E, Fiaschi T, and Chiarugi P: Anoikis: an emerging hallmark in health and diseases. J Pathol 226, 380–393, 2012.
  • Rendon BE, Roger T, Teneng I, Zhao M, Al-Abed Y, et al.: Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 282, 29910–29918, 2007.
  • Reddig PJ and Juliano RL: Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev 24, 425–439, 2005.
  • Ng TL, Leprivier G, Robertson MD, Chow C, Martin MJ, et al.: The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Cell Death Differ 19, 501–510, 2012.
  • Cimen I, Tuncay S, and Banerjee S: 15-Lipoxygenase-1 expression suppresses the invasive properties of colorectal carcinoma cell lines HCT-116 and HT-29. Cancer Sci 100, 2283–2291, 2009.
  • Hwangbo C, Kim J, Lee JJ, and Lee JH: Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase c alpha and the PDZ adapter protein mda-9/syntenin. Cancer Res 70, 1645–1655, 2010.
  • Meng XN, Jin Y, Yu Y, Bai J, Liu GY, et al.: Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Brit J Cancer 101, 327–334, 2009.
  • Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, et al.: Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agr Food Chem 51, 7907–7912, 2003.
  • Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS, et al.: Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. J Agr Food Chem 58, 2935–2942, 2010.
  • Hsu HH, Liu CJ, Shen CY, Chen YJ, Chen LM, et al.: p38 alpha MAPK mediates 17 beta-estradiol inhibition of MMP-2 and -9 expression and cell migration in human lovo colon cancer cells. J Cell Physiol 227, 3648–3660, 2012.
  • Kumar B, Koul S, Petersen J, Khandrika L, Hwa JS, et al.: p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res 70, 832–841, 2010.
  • Pories SE, Zurakowski D, Roy R, Lamb CC, Raza S, et al.: Urinary metalloproteinases: Noninvasive biomarkers for breast cancer risk assessment. Cancer Epidem Biomar 17, 1034–1042, 2008.
  • Gimona M, Kaverina I, Resch GP, Vignal E, and Burgstaller G: Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol Biol Cell 14, 2482–2491, 2003.
  • Lin Y, Buckhaults PJ, Lee JR, Xiong H, Farrell C, et al.: Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer. Neoplasia 11, 864–873, 2009.
  • Adam PJ, Regan CP, Hautmann MB, and Owens GK: Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J Biol Chem 275, 37798–37806, 2000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.